The authors describe a validation master plan for closed-vial filling technology.
Benoit Verjans
Advertisement
Articles by Benoit Verjans
The authors compare the exposure risk from viable particles from the air supply in four well-established aseptic filling technologies.
Advertisement
Latest Updated Articles
In-Depth Validation of Closed-Vial TechnologyPublished: September 1st 2012 | Updated:
Assessing Filling Technologies For Contamination RiskPublished: March 1st 2012 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Trends in Formulation eBook October 2025
2
In KPMG's CEO Outlook, AI, Regulatory Demands, and Supply Chain Risk Rank High
3
New Cellevate Nanofiber Microcarriers Aim to Transform Vaccine Manufacturing Processes
4
Analytics, Automation, and Quality Driving the Next Era of Drug Development
5
